OCT 11, 2018 1:30 PM PDT

Breast Cancer as a Global Disease: Are We Up to The Challenge?

Speaker
  • Professor of Surgery, Division of General Surgery (Surgical Oncology Section), University of Washington School of Medicine
    Biography
      Dr. Anderson's is an internationally recognized leader in global cancer control. With joint appointments at the Fred Hutchinson Cancer Research Center Division of Public Health Sciences and the UW Department of Global Health, Dr. Anderson created in 2002 and continues to chair the Breast Health Global Initiative (BHGI), a unique program to develop "resource-stratified" guidelines for breast cancer early detection, diagnosis, treatment and palliative care in low- and middle-income countries (LMICs). In 2011 the American Society of Clinical Oncology (ASCO) awarded Dr. Anderson their Partners in Progress Award and in 2013 the National Consortium of Breast Centers (NCBC) awarded him their 2013 Inspiration Award, recognizing his dedicated efforts to improve the quality and effectiveness of breast cancer care around the globe. Since 2012, Dr. Anderson has served on the Board of Directors of the Union for International Cancer Control (UICC). Dr. Anderson now co-chairs the Breast Cancer Initiative 2.5 (BCI2.5), a global campaign to reduce disparities in breast cancer outcomes for 2.5 million women between now and 2025.

    Abstract

    As the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 1990 due to improved early detection and timely treatment.  By contrast, most breast cancer deaths occur in low and middle income countries (LMICs).  The Breast Health Global Initiative (BHGI) developed resource-stratified guidelines as a framework for breast cancer management in limited resource environments.  Pilot studies from Latin America, Asia and sub-Saharan Africa use implementation research methods to demonstrate best practices that improve outcome despite resource constraints. “Phased implementation” is a novel approach to guide strategic program development to save breast cancer lives.

    Learning Objectives: 

    1. Understand why breast cancer mortality has dropped in the U.S. by 35% since 1990
    2. Understand why breast cancer is the most likely reason that a woman will die of cancer around the world


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 11, 2018 1:30 PM PDT

    Breast Cancer as a Global Disease: Are We Up to The Challenge?


    Specialty

    Cancer Research

    Genetics

    Cancer

    Cell

    Cancer Diagnostics

    Gene Expression

    Oncology

    Dna

    Biomarkers

    Animal Models

    Molecular Biology

    Antibodies

    Animal Sciences

    Disease

    Research

    Geography

    North America50%

    Asia25%

    Europe25%

    Registration Source

    Website Visitors100%

    Job Title

    Student40%

    Pharmacist10%

    Clinical Laboratory Scientist10%

    Executive10%

    Medical Doctor/Specialist10%

    Research Scientist10%

    Medical Laboratory Technician10%

    Organization

    Hospital25%

    Academic Institution25%

    Research Institute8%

    Biotech Company8%

    Contract Research Organization (Cro)8%

    Medical Center8%

    Other17%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more